Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Berndt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Health Economics|August 18, 2000
International comparisons of pharmaceutical prices: what do we know, and what does it mean?E R Berndt
Health Affairs (Project Hope)|March 23, 2001
The U.S. pharmaceutical industry: why major growth in times of cost containment?E R Berndt
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
The American Journal of Managed Care|January 7, 1997
Alternative insurance arrangements and the treatment of depression: what are the facts?E R Berndt, R G Frank, T G McGuire
The American Economic Review|April 8, 1995
Information, marketing, and pricing in the U.S. antiulcer drug marketE R Berndt, L Bui, D R Reiley, et al.
Business and Health|July 1, 1999
When antihistamines go to workI M Cockburn, H L Bailit, E R Berndt, et al.
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
Journal of Occupational and Environmental Medicine|November 26, 1999
Loss of work productivity due to illness and medical treatmentI M Cockburn, H L Bailit, E R Berndt, et al.
The American Journal of Managed Care|October 28, 1999
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertralineJ M Russell, E R Berndt, R Miceli, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Health Economics|August 18, 2000
International comparisons of pharmaceutical prices: what do we know, and what does it mean?E R Berndt
Health Affairs (Project Hope)|March 23, 2001
The U.S. pharmaceutical industry: why major growth in times of cost containment?E R Berndt
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
The American Journal of Managed Care|January 7, 1997
Alternative insurance arrangements and the treatment of depression: what are the facts?E R Berndt, R G Frank, T G McGuire
The American Economic Review|April 8, 1995
Information, marketing, and pricing in the U.S. antiulcer drug marketE R Berndt, L Bui, D R Reiley, et al.
Business and Health|July 1, 1999
When antihistamines go to workI M Cockburn, H L Bailit, E R Berndt, et al.
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
Journal of Occupational and Environmental Medicine|November 26, 1999
Loss of work productivity due to illness and medical treatmentI M Cockburn, H L Bailit, E R Berndt, et al.
The American Journal of Managed Care|October 28, 1999
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertralineJ M Russell, E R Berndt, R Miceli, et al.
Pageof 2